4//SEC Filing
FREEMAN KEVIN D 4
Accession 0001133416-24-000062
CIK 0001133416other
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 8:02 AM ET
Size
6.0 KB
Accession
0001133416-24-000062
Insider Transaction Report
Form 4
FREEMAN KEVIN D
Director
Transactions
- Purchase
Common Stock
2024-12-24$0.81/sh+10,000$8,134→ 44,769 total
Holdings
- 80,000(indirect: By LLC)
Common Stock
- 18,063(indirect: By IRA)
Common Stock
Footnotes (1)
- [F1]Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeother
Related Parties
1- filerCIK 0001522478
Filing Metadata
- Form type
- 4
- Filed
- Dec 25, 7:00 PM ET
- Accepted
- Dec 26, 8:02 AM ET
- Size
- 6.0 KB